Cargando…
Response to COVID‐19 vaccine is reduced in patients with inflammatory bowel disease, but improved with additional dose
BACKGROUND: Coronavirus disease 2019 (COVID‐19) vaccination is recommended for patients with inflammatory bowel disease (IBD); however, suppressed immune responses have been reported for fully vaccinated patients under immunosuppressive therapy, mainly from Western countries. We prospectively analyz...
Autores principales: | Shiga, Hisashi, Kakuta, Yoichi, An, Kumiko, Abe, Yuko, Fujimaki, Shinichi, Shimoyama, Yusuke, Naito, Takeo, Moroi, Rintaro, Kuroha, Masatake, Khor, Seik‐Soon, Kawai, Yosuke, Tokunaga, Katsushi, Kinouchi, Yoshitaka, Masamune, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537921/ https://www.ncbi.nlm.nih.gov/pubmed/36066279 http://dx.doi.org/10.1111/jgh.16001 |
Ejemplares similares
-
Validity of Diagnostic Algorithms for Inflammatory Bowel Disease in Japanese Hospital Claims Data
por: Takahashi, Sayumi, et al.
Publicado: (2022) -
A pilot study investigating the safety and feasibility of endoscopic dilation using a radial incision and cutting technique for benign strictures of the small intestine: a study protocol
por: Moroi, Rintaro, et al.
Publicado: (2022) -
Long‐term effectiveness of ustekinumab comparable to antitumor necrosis factor agents in patients with Crohn's disease
por: Shiga, Hisashi, et al.
Publicado: (2022) -
TL1A (TNFSF15) genotype affects the long‐term therapeutic outcomes of anti‐TNFα antibodies for Crohn's disease patients
por: Endo, Katsuya, et al.
Publicado: (2020) -
Liquid Biopsy for Colorectal Adenoma: Is the Exosomal miRNA Derived From Organoid a Potential Diagnostic Biomarker?
por: Handa, Tomoyuki, et al.
Publicado: (2021)